Growth Hormone Secretion and Growth in Central Nervous System Irradiated Children

  • R. Rappaport
  • M. Fontoura
  • R. Brauner
Part of the Serono Symposia, USA book series (SERONOSYMP)


External cranial irradiation is currently used in various therapeutic protocols for malignant systemic and intracranial diseases. Some patients receive spinal irradiation in addition. These therapies have significantly improved the survival rate in a number of malignant systemic or cranial diseases. The impact of radiotherapy on growth and the mechanism of growth retardation observed in these patients has generated much interest. Earlier data, although demonstrating late effects on growth, have often been difficult to interpret. In fact, several factors may contribute to growth retardation, such as age at irradiation, doses delivered to the hypothalamic-pituitary region, chemotherapy and glucocorticoids, spinal irradiation and other endocrine abnormalities involving gonadotropin secretion or thyroid dysfunction. For practical purposes it is also important to analyze the data according to the diseases, each of which involves a different treatment protocol.


Growth Hormone Acute Lymphoblastic Leukemia Growth Hormone Secretion Precocious Puberty Cranial Irradiation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sainsbury CPQ, Newcombe RG, Hughes IA. Weight gain and height velocity during prolonged first remission from acute lymphoblastic leukemia. Arch Dis Child 1985; 60: 832–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Dacou-Voutetakis C, Xypolyta A, Haidas S, Constantinidis M, Papavasiliou C, Zannos-Mariolea L. Irradiation of the head. Imme-diate effect on growth hormone secretion in children. J Clin Endocrinol Metab 1977; 44: 791–4.PubMedCrossRefGoogle Scholar
  3. 3.
    Price DA, Shalet SM, Beardwell CG, Hann IM, Jones PHM. Serum somatomedin activity (SMact) in children with acute lymphoblastic leukaemia (ALL). Pediatr Res 1978; 12: 159.CrossRefGoogle Scholar
  4. 4.
    Shalet SM. Irradiation induced growth failure. Clin Endocrinol Metab 1986; 15(3).Google Scholar
  5. 5.
    Starceski PJ, Lee PA, Blatt J, Finegold D, Brown D. Comparable effects of 1800- and 2400-rad (18- and 24-Gy) cranial irradiation on height and weight in children treated for acute lymphocytic leukemia. Am J Dis Child 1987; 141: 550–2.PubMedGoogle Scholar
  6. 6.
    Robison LL, Nesbit ME, Sather HN, et al. Height of children successfully treated for acute lymphoblastic leukemia: a report from the late effects study committee of Children’s Cancer Study Group. Med Pediatr Oncol 1985; 13: 14–21.PubMedCrossRefGoogle Scholar
  7. 7.
    Brauner R, Czernichow P, Rappaport R. Croissance staturale apres irradiation du systeme nerveux central pour medulloblastome de la fosse posterieure. Analyse retrospective de 45 observations. Arch Fr Pediatr 1985; 42: 219–23.PubMedGoogle Scholar
  8. 8.
    Brauner R, Czernichow P, Prevot C, Guyda HJ, Rappaport R. Longitudinal study of GH secretion, somatomedin and growth in the two years following cranial irradiation. Pediatr Res 1985; 19: 613.CrossRefGoogle Scholar
  9. 9.
    Shalet SM, Gibson B, Swindell R, Pearson D. Effect of spinal irradiation on growth. Arch Dis Child 1987; 62: 461–4.PubMedCrossRefGoogle Scholar
  10. 10.
    Probert JC, Bruce FFR, Parker R, Kaplan HS. Growth retardation in children after megavoltage irradiation of the spine. Cancer 1973; 32: 634–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Rappaport R, Brauner R, Czernichow P, et al. Effect of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors. J Clin Endocrinol Metab 1982; 54: 1164–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Brauner R, Czernichow P, Rappaport R. Precocious puberty after hypothalamic and pituitary irradiation in young children. N Engl J Med 1984; 311: 920.PubMedGoogle Scholar
  13. 13.
    Winter RJ, Green OC. Irradiation-induced growth hormone deficiency: blunted growth response and accelerated skeletal maturation to growth hormone therapy. J Pediatr 1985; 106: 609–12.PubMedCrossRefGoogle Scholar
  14. 14.
    Tan BC, Kunaratnam N. Hypopituitary dwarfism following radiotherapy for nasopharyngeal carcinoma. Clin Radiol 1966; 17: 302–4.PubMedCrossRefGoogle Scholar
  15. 15.
    Larkins RG, Martin FIR. Hypopituitarism after extracranial irradiation: evidence for hypothalamic origin. Br Med J [Clin Res] 1973; i:152–3.Google Scholar
  16. 16.
    Shalet SM, Beardwell CG, Morris-Jones PH, Pearson D. Pituitary function after treatment of intracranial tumours in children. Lancet 1975; 3: 104–7.CrossRefGoogle Scholar
  17. 17.
    Richards GE, Wara WM, Grumbach MM, Kaplan SL, Sheline GE, Conte FA. Delayed onset of hypopituitarism: sequelae of therapeutic irradiation of central nervous system, eye, and middle ear tumors. J Pediatr 1976; 89: 553–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Perry-Keene DA, Connelly JF, Young RA, Wettenhall HNB, Martin FIR. Hypothalamic hypopituitarism following external radiotherapy for tumours distant from the adenohypophysis. Clin Endocrinol (Oxf) 1976; 5: 373–80.CrossRefGoogle Scholar
  19. 19.
    Czernichow P, Cachin 0, Rappaport R, Flamant F, Sarrazin D, Schweisguth O. Sequelles endocriniennes des irradiations de la tete et du cou pour tumeurs extracraniennes. Arch Fr Pediatr 1977; 34:CLIV-XIV.Google Scholar
  20. 20.
    Samaan NA, Bakdash MM, Caderao JB, Cangir A, Jesse RH, Ballantyne AJ. Hypopituitarism after external irradiation. Evidence for both hypothalamic and pituitary origin. Ann Intern Med 1975; 83: 771–7.PubMedGoogle Scholar
  21. 21.
    Spiliotis BE, August GP, Hung W, Sonis W, Mendelson W, Bereu BB. Growth hormone neurosecretory dysfunction. A treatable cause of short stature. JAMA 1984; 251: 2223–30.PubMedCrossRefGoogle Scholar
  22. 22.
    Mosier HD, Jansons RA, Swingle KF, Sondhaus CA, Dearden LC, Halsall LC. Growth hormone secretion in the stunted head-irradiated rat. Pediatr Res 1985; 19: 543–8.PubMedGoogle Scholar
  23. 23.
    Mosier HD, Jansons RA. Pituitary content of somatotropin, gonadotropin, and thyrotropin in rats with stunted linear growth following head X-irradiation. Proc Soc Exp Biol Med 1968; 128: 23–6.PubMedGoogle Scholar
  24. 24.
    Chrousos GO, Poplack D, Brown T, et al. Effects of cranial radiation on hypothalamic-adenohypophyseal function: abnormal growth hormone secretory dynamics. J Clin Endocrinol Metab 1982; 54: 1135–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Dickinson WP, Berry DH, Dickinson L, et al. Differential effects of cranial radiation on growth hormone response to arginine and insulin infusion. J Pediatr 1978; 92: 754–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Romshe CA, Zipf WB, Miser A, Miser J, Sotos JF, Newton WA. Evaluation of growth hormone release and human growth hormone treatment in children with cranial irradiation-associated short stature. J Pediatr 1984; 104: 177–81.PubMedCrossRefGoogle Scholar
  27. 27.
    Ahmed SR, Shalet SM, Beardwell CG. The effects of cranial irradiation on growth hormone secretion. Acta Paediatr Scand 1986; 75: 255–60.PubMedCrossRefGoogle Scholar
  28. 28.
    Blatt J, Bercu BB, Gillin JC, Mendelson WB, Poplack DG. Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia. J Pediatr 1984; 104: 182–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Brauner R, Prevot C, Roy MP, Rappaport R. Growth, growth hormone secretion and somatomedin C after cranial irradiation for acute lymphoblastic leukemia. Acta Endocrinol (Copenh) 1986; 279 (suppl): 178–82.Google Scholar
  30. 30.
    Shalet SM, Price DA, Beardwell CG, Morris-Jones PH, Pearson D. Normal growth despite abnormalities of growth hormone secretion in children treated for acute leukemia. J Pediatr 1979; 94: 719–22.PubMedCrossRefGoogle Scholar
  31. 31.
    Ahmed SR, Shalet SM. Hypothalamic growth hormone releasing factor deficiency following cranial irradiation. Clin Endocrinol (Oxf) 1984; 21: 483–8.CrossRefGoogle Scholar
  32. 32.
    Lustig RH, Schriok EA, Kaplan SL, Grumbach MM. Effect of growth hormone-releasing factor on growth hormone release in children with radiation-induced growth hormone deficiency. Pediatrics 1985; 76: 274–9.PubMedGoogle Scholar
  33. 33.
    Crosnier H, Brauner R, Prevot C, Rappaport R. GH response to hGRF as a sensitive index of GH neurosecretory dysfunction after cranial irradiation. Pediatr Res 1986; 20: 1189.CrossRefGoogle Scholar
  34. 34.
    Pomarede R, Czernichow P, Zucker JM, et al. Incidence of anterior pituitary deficiency after radiotherapy at an early age: study in retinoblastoma. Acta Paediatr Scand 1984; 73: 115–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Shalet SM, Beardwell CG, Pearson D, Morris-Jones PH. The effect of varying doses of cerebral irradiation on growth hormone production in childhood. Clin Endocrinol (Oxf) 1976; 5: 287–90.CrossRefGoogle Scholar
  36. 36.
    Brauner R, Czernichow P, Rappaport R. Greater susceptibility to hypothalamopituitary irradiation in younger children with acute lymphoblastic leukemia. J Pediatr 1986; 108: 332.PubMedGoogle Scholar
  37. 37.
    Shalet SM, Beardwell CG, Morris-Jones PH, Pearson D. Growth hormone deficiency after treatment of acute leukaemia in children. Arch Dis Child 1976; 51: 489–93.PubMedCrossRefGoogle Scholar
  38. 38.
    Saunders JE, Pritchard S, Mahoney P, et al. Growth and development following marrow transplantation for leukemia. Blood 1986; 68: 1129–35.Google Scholar
  39. 39.
    Shalet SM, Whitehead E, Chapman AJ, Beardwell CG. The effects of growth hormone therapy in children with radiation-induced growth hormone deficiency. Acta Paediatr Scand 1981: 70: 81–6.PubMedCrossRefGoogle Scholar
  40. 40.
    Kaplan SL, August GP, Blethen SL, et al. Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficient children. Lancet 1986; 1: 697–700.PubMedCrossRefGoogle Scholar
  41. 41.
    Arslanian SA, Becker DJ, Lee PA, Drash AL, Foley TP. Growth hormone therapy and tumor recurrence. Am J Dis Child 1985; 139: 347–50.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • R. Rappaport
    • 1
  • M. Fontoura
    • 1
  • R. Brauner
    • 1
  1. 1.Unit of Pediatric Endocrinology and DiabetesHopital des Enfants MaladesParisFrance

Personalised recommendations